By Nnamdi Odumody
Around one, in every eight essential medicines, in lower income countries, may be of low quality or an outright fake. Substandard and fake drugs, don’t just fail to treat disease, they can prolong illness, heighten the risk of treatment failure, poisoning, and severe drug interactions. The implication is monumental risk to life. Also, fake drugs can contribute to antimicrobial resistance, posing a threat to the effectiveness of future treatments.
A near death experience, after consumption of fake drug 15 years ago in Ibadan, prompted Adebayo Alonge to embark on a mission, aimed at preventing loss of lives, due to fake drugs. Deaths attributed to fake drugs are common experiences in Nigeria and other developing countries. Adebayo, on his mission, studied Pharmacy at the University of Ibadan, emerging the best graduating student. Over the years, he has gathered experiences in business, developing projects worth over $180 million in consulting, pharmaceuticals and technology startups before founding RxAll with Amy Kao and Wei Liu in 2016. The technical capability and business exposure will certainly cushion him to build a category-king business in this domain. Nigeria cannot wait!
Tekedia Mini-MBA edition 16 (Feb 10 – May 3, 2025) opens registrations; register today for early bird discounts.
Tekedia AI in Business Masterclass opens registrations here.
Join Tekedia Capital Syndicate and invest in Africa’s finest startups here.
Our platform uses a proprietary molecular sensor device with a cloud-based IP-protected AI algorithm and database of spectral signatures of drugs- both prescription and recreational- to carry out non-destructive drug authentication.
We work with drug regulators and other stakeholders to reduce branded drug counterfeiting and ensure that patients receive high quality authenticated drugs. Pharma manufacturers increase sales and patients have better access to high quality drugs.
RxAll is a hyper spectral platform which leverages artificial intelligence and blockchain technology for drug quality authentication and tracking. It uses a proprietary molecular sensor device (RxScanner, the world’s first drug authenticator), with a cloud based IP protected AI algorithm and database of spectral signatures of drugs, both prescription and recreational, to carry out non-destructive drug authentication.
They work with drug regulators and other stakeholders to reduce branded drug counterfeiting and ensure that patients receive high quality authenticated drugs. The platform enables patients to buy high quality drugs from trusted offline-pharmacies, who use their AI-enabled inventory software, to ensure availability. Also, they pool the procurement of their network pharmacies, enabling patients to get the lowest prices. This makes patients save time by ensuring they don’t leave the confines of their homes to get high quality non-counterfeit products. Also, ‘’telepharmacare’’ is available on demand.
It offers an alternative sales channel for pharmacies that need an omnichannel sales strategy. The RxAll AI-inventory software is provided free of charge.
RxAll won the 2019 Hello Tomorrow Prize of 100,000 euros for Best Early Stage Startup beating 4500 contenders from 119 nations. Hello Tomorrow is a world’s deep Tech Conference for scientists, technologists and their enablers. They are currently operational in Canada, China, Myanmar, Kenya, Uganda, Ghana and Nigeria.